Supernus Pharmaceuticals, Inc.
SUPNNasdaqCIK 1356576HealthcareFiscal year ends Dec 31
Reports and events: 426 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:12 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001356576-26-000051 |
| 2026-10-2916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000050 |
| 2026-10-2616:41 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001356576-26-000045 |
| 2026-10-2221:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117937 |
| 2026-10-1916:51 ET | 8-K | 2.02 Results of operations | 0001356576-26-000043 |
| 2026-10-1516:10 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001356576-26-000040 |
| 2026-08-0317:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-089839 |
| 2026-08-0308:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-089524 |
| 2026-08-0306:56 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001356576-26-000037 |
| 2026-08-0306:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000035 |
| 2026-08-0306:43 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-089425 |
| 2026-07-2217:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000031 |
| 2026-06-1816:55 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001356576-26-000028 |
| 2026-05-2016:37 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001356576-26-000025 |
| 2026-05-0516:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001356576-26-000022 |
| 2026-05-0516:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000020 |
| 2026-04-3017:00 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001104659-26-053111 |
| 2026-04-2216:32 ET | 8-K | 2.02 Results of operations | 0001356576-26-000015 |
| 2026-04-0717:25 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-26-040497 |
| 2026-03-0216:40 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001356576-26-000011 |
| 2026-02-2416:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001356576-26-000007 |
| 2026-02-2416:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000004 |
| 2026-02-1216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000002 |
| 2026-01-2817:28 ET | 8-K | 9.01 Financial statements and exhibits | 0001628280-26-003907 |
| 2025-11-0617:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001356576-25-000071 |
| 2025-11-0416:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001356576-25-000068 |
| 2025-10-2117:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-25-000065 |
| 2025-10-1616:11 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001356576-25-000062 |
| 2025-08-0516:24 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001356576-25-000055 |
| 2025-08-0516:18 ET | 8-K | 2.02 Results of operations | 0001356576-25-000053 |
| 2025-08-0418:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001356576-25-000050 |
| 2025-07-3108:58 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-072506 |
| 2025-07-2216:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-25-000046 |
| 2025-06-1716:40 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001356576-25-000042 |
| 2025-06-1608:34 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-059687 |
| 2025-05-2816:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001356576-25-000038 |
| 2025-05-0616:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001356576-25-000033 |
| 2025-05-0616:14 ET | 8-K | 2.02 Results of operations | 0001356576-25-000031 |
| 2025-04-3016:17 ET | DEF 14A | Proxy statementPeriod 2025-06-16 | 0001104659-25-042531 |
| 2025-04-2317:20 ET | 8-K | 2.02 Results of operations | 0001356576-25-000020 |
| 2025-02-2516:13 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001356576-25-000017 |
| 2025-02-2516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-25-000015 |
| 2025-02-2416:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001356576-25-000011 |
| 2025-02-1816:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001356576-25-000008 |
| 2025-02-1117:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-25-000006 |
| 2025-02-0416:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001356576-25-000004 |
| 2025-01-2716:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001356576-25-000002 |
| 2024-12-2016:10 ET | 8-K | 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001356576-24-000069 |
| 2024-11-0416:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001356576-24-000067 |
| 2024-11-0416:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-24-000065 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.